Literature DB >> 8466070

Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane.

S N Markovic1, P R Knight, D M Murasko.   

Abstract

BACKGROUND: Basal cytotoxic activity of NK cells, a subtype of lymphocytes involved in the nonspecific immune response to viruses, tumors, and some bacteria, is altered in the postoperative period. The current study examines the effects of halothane and isoflurane on interferon-induced stimulation of NK cell cytotoxicity in vivo and in vitro.
METHODS: Mice were exposed to either anesthetic on days 10, 5, 1, or -1 relative to interferon treatment on day 0. NK cytotoxicity was assessed 24 h later. Similarly, splenic mononuclear cells containing NK cells were treated with interferon, before or after in vitro exposure with either halothane or isoflurane, and cytotoxicity was determined.
RESULTS: In vivo, isoflurane or halothane inhibited subsequent interferon-induced NK cell stimulation (> 90% and 67%, respectively). No inhibition occurred if interferon was given before anesthetic exposure. Significant inhibition of interferon-induced NK cell stimulation could be observed 11 days after anesthesia. In vitro, both anesthetics inhibited the subsequent stimulation of NK cytotoxicity by interferon, however, cytotoxicity of NK cells treated with interferon before anesthetic exposure was comparable to untreated interferon-stimulated NK cells.
CONCLUSIONS: Halothane and isoflurane inhibit interferon stimulation of NK cytotoxicity in naive (unstimulated) NK cells of the splenic mononuclear cell pool without affecting the cytotoxicity of previously stimulated (interferon) NK cells. This could occur directly by preventing the NK cell from responding or indirectly by altering other cells in the splenic mononuclear cell pool (T cells, macrophages), which then inhibit NK cell induction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466070     DOI: 10.1097/00000542-199304000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  41 in total

Review 1.  The role of epidural anesthesia and analgesia in surgical practice.

Authors:  Robert J Moraca; David G Sheldon; Richard C Thirlby
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

Review 2.  [Current aspects of anesthetic management in urological patients].

Authors:  O Groll; J Peters
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 3.  Anesthetics, immune cells, and immune responses.

Authors:  Shin Kurosawa; Masato Kato
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

4.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 5.  [Influence of anesthesia procedure on malignant tumor outcome].

Authors:  K Fukui; C Werner; G Pestel
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

6.  Anesthetic techniques and recurrence of breast cancer: unanswered questions.

Authors:  Ryungsa Kim; Takanori Kin
Journal:  Gland Surg       Date:  2020-04

7.  Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment.

Authors:  Jarrod D Predina; Brendan Judy; Veena Kapoor; Aaron Blouin; Louis A Aliperti; Daniel Levine; Olugbenga T Okusanya; Jon Quatromoni; Zvi G Fridlender; Sunil Singhal
Journal:  Am J Transl Res       Date:  2012-04-10       Impact factor: 4.060

8.  Halothane modulates the type i interferon response to influenza and minimizes the risk of secondary bacterial pneumonia through maintenance of neutrophil recruitment in an animal model.

Authors:  Brian A MacDonald; Krishnan V Chakravarthy; Bruce A Davidson; Barbara A Mullan; Ravi Alluri; Anders P Hakansson; Paul R Knight
Journal:  Anesthesiology       Date:  2015-09       Impact factor: 7.892

Review 9.  Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors:  Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2020-02-17       Impact factor: 66.675

10.  Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumonia.

Authors:  Patricia A Manderscheid; Ryan P Bodkin; Bruce A Davidson; Erik Jensen; Thomas A Russo; Paul R Knight
Journal:  Clin Diagn Lab Immunol       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.